Trial intelligence / Profile preview

Botulax vs Botox in Children with Cerebral Palsy

NCT01787344Phase 3Completed

Sponsor
Hugel
Start
Mar 2012
Primary completion
Jun 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Hugel. Started Mar 2012; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT01787344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01787344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call